Danishefsky
Sam Danishefsky, Englewood, NJ US
Patent application number | Description | Published |
---|---|---|
20150110807 | HDC-SIGN BINDING PEPTIDES - Polypeptides that bind to DC-SIGN and/or its homologues and methods for using such peptides for the treatment of various disorders are described. DC-SIGN and its homologues are receptors that bind IgG antibodies or Fc fragments and mediate intravenous immunoglobulin (IVIG)-related reversal of inflammation associated with various immune disorders. | 04-23-2015 |
Samuel Danishefsky, Englewood, NJ US
Patent application number | Description | Published |
---|---|---|
20110269969 | TOTAL SYNTHESIS OF SALINOSPORAMIDE A AND ANALOGS THEREOF - The present application relates to certain compounds and to methods for the preparation of certain compounds that can be used in the fields of chemistry and medicine. Specifically, described herein are methods for the preparation of various compounds and intermediates, and the compounds and intermediates themselves. More specifically, described herein are methods for synthesizing Salinosporamide A and its analogs that includes forming a compound of formula (VIII). | 11-03-2011 |
20130012720 | TOTAL SYNTHESIS OF SALINOSPORAMIDE A AND ANALOGS THEREOF - The present application relates to certain compounds and to methods for the preparation of certain compounds that can be used in the fields of chemistry and medicine. Specifically, described herein are methods for the preparation of various compounds and intermediates, and the compounds and intermediates themselves. More specifically, described herein are methods for synthesizing Salinosporamide A and its analogs that includes forming a compound of formula (VIII). | 01-10-2013 |
Samuel Danishefsky, New York, NY US
Patent application number | Description | Published |
---|---|---|
20150283227 | SYNTHETIC ENV PROTEINS - The present invention relates, in general, to human immunodeficiency virus-1 (HIV-1), and, in particular to a vaccine for HIV-1 and to methods of making and using same. The present invention provides synthetic glycosylated HIV-1 peptides, method for their preparation and use. | 10-08-2015 |